Cytopathological pattern of cervical pap smears-a study among population of North Malabar in Kerala

Nair, Geethu G.; Shamsuddin, Fatima; Narayanan, Thidil; Balan, Prejisha

doi:10.5958/2394-6792.2016.00103.4

Cited by 11 publications

(18 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…10,11 A study in Kerala, in North Malabar shows a prevalence of 2.42%. 12 In this study it was 2.15%. This is lower than the prevalence in different studies conducted worldwide-Saudi Arabia, America, S. Africa, Bangladesh but higher than Nepal and Tehran as shown in Table 2.…”

Section: Discussionsupporting

confidence: 45%

Profile of PAP smears done in a tertiary centre in North Kerala

Thomas¹,

Kumaran²

2018

Int J Community Med Public Health

View full text Add to dashboard Cite

Background: In India, cervical cancer is the second most common cancer among women. WHO sponsored expert group meeting on “Strategies for Cervical cancer Control” recommends women of 30-59 years as target group for cervical cancer screening in India. Statistics show us that routine cervical cancer screening is not happening in India.Methods: This is a retrospective, descriptive, record based study done in a private medical college in Northern Kerala to study the profile of PAP smears during the years, 2014 and 2015 and to find out the appropriateness of the recommendations for age for cervical cancer screening. The data regarding cervical smears were analyzed using Epi info software.Results: A total of 3059 cervical smears were analyzed retrospectively. The age group of the study population ranged from 21 years to 93 years with the mean age of 46.3942±13.7 SD. Of all the smears, 2993 (97.84%) were Negative for intraepithelial lesion or malignancy (NILM). A total of 66 smears (2.15%) showed epithelial abnormality. All precancerous lesions, LSIL (29.03%), HSIL (37.04%) and Atypia (37.5%) were most commonly found in the age group of 61-70 years.Conclusions: The incidence of epithelial abnormality is found increasingly in older age groups. Limiting the target population for screening to 30-59 years, will result in missing out of many cases with precancerous lesions which in turn may fail our attempts in reducing the burden of cervical cancer. So a higher age group as target population needs to be set.

show abstract

Section: Discussionsupporting

confidence: 45%

Profile of PAP smears done in a tertiary centre in North Kerala

Thomas¹,

Kumaran²

2018

Int J Community Med Public Health

View full text Add to dashboard Cite

show abstract

“…In our study, epithelial cell abnormality was observed in more younger age groups of women as compared to many studies. [ 17 18 19 20 21 22 23 24 25 26 ] This fact highlights the need for cytological screening in these groups as well as in older age group. There is a need to create awareness about cervical cancer among women and motivate them to attend such screening time to time as medical health checkup.…”

Section: Discussionmentioning

confidence: 99%

A study on cervical cancer screening in asymptomatic women using Papanicolaou smear in a tertiary care hospital in an urban area of Mumbai, India

Shaki

Chakrabarty²,

Nagaraja³

2018

J Family Med Prim Care

View full text Add to dashboard Cite

Introduction:Cervical cancer is the most common cause of death among women in developing countries. Among the Indian women, cervical cancer is the most common genital tract cancer. Papanicolaou (Pap) smear test plays a vital role in the detection of cervical cancer even in its premalignant condition. The aim of this study to evaluate the role of Pap smear in detecting premalignant and malignant lesions as well as nonneoplastic lesions of the cervix and to determine the prevalence of various lesions.Materials and Methods:We screened 1100 women in the age group of 21–65 years who attended our medical camp organized by the hospital in outdoor patient department. All women was willing to give consent for screening by Pap smear test were included.Results:Of 1100 cases, majority of the cases were benign comprising negative for intraepithelial neoplasia (NILM) of about 581 (52.8%) cases, 203 (18.4%) inflammatory, atypical squamous cells of undetermined significance 45 (4%), low-grade squamous intraepithelial lesion (LSIL) in 75 (6.8%), and high-grade squamous intraepithelial lesion (HSIL) in 74 (6%) women. Overall sensitivity and specificity for the detection of LSIL were 75.8% and 94.6% and those for the detection of HSIL were 68.9% and 98.6%.Conclusions:Pap smear test is a very easy, noninvasive, useful, simple, safe, and very economical tool to detect preinvasive cervical epithelial lesions. It is evident and proven that every woman above the age of 30–35 years must be subjected to cervical screening and this must be continued even in the postmenopausal period.

show abstract

“…Percentage of unsatisfactory smears Crasta et al [12] 1.36% Nair et al [6] 2.7% Shankarnarayanan et al [13] 4.1% Present study 5.9% Patel et al [3] 11.9% Kalyani et al [4] 17.8% [14,15] . The present study had ECA in 6.1% of cases which is approximated to the studies conducted by Patel et al, (5.5%, 995 females) and Misra et al (7.7%, 36484 females) [3,16] .…”

Section: Studymentioning

confidence: 88%

“…In our study, cervical cancer was noted between 39-65 years. 4) [3,4,6,12,13] . The unsatisfactory rate is an important quality assurance indicator in cervical cytology as it identifies women who are being inadequately screened.…”

Section: 2mentioning

confidence: 99%

“…Repeated Pap smear screening is recommended as cervix desquamates irregularly and hence repeated testing over time increases the chances of detecting a missed abnormality in a previous testing [5] . Implementation of revised Bethesda System has unified various overlapping terminologies and created a standardized framework for laboratory reports that includes a descriptive diagnosis and an evaluation of specimen adequacy [6] . The present study aims to evaluate the spectrum and prevalence of epithelial cell abnormalities (ECAs) using revised Bathesda system in females attending a tertiary care hospital.…”

mentioning

confidence: 99%

See 1 more Smart Citation

A study on cervical pap screening with clinical correlation in a tertiary care hospital

Nagpal¹,

Kshitija²,

Paul³

et al. 2020

Int. J. Clin. Diagn. Pathol.

View full text Add to dashboard Cite

Background: Cervical cancer is the leading cause of death in women in developing countries like India. It is preventable by regular screening by Pap smear and can be detected at pre-invasive stage. Thus, reducing the morbidity and mortality related with cervical cancers. Objective: This study aims at detecting the prevalence and current trends of various epithelial cell abnormalities (ECAs) in females attending a tertiary care hospital. Materials and Methods: This is a retrospective study conducted in a tertiary care hospital between July 2018 and Dec 2019. A total of 4280 cases of conventional Pap smears were included in the study. Clinical data and history of the patients were retrieved. All cases were reported according to Bethesda system. Results: Among 4280 cases, 256 Pap smears were unsatisfactory, 3762 Pap smears were negative for intraepithelial lesion/malignancy (NILM), and 262 cases had ECA. Conclusion: Large hospital-based studies are required for proper implementation of health services as well as sensitive screening test for early detection of cervical abnormalities which can be helpful in decreasing the burden of cervical cancer in our community.

show abstract

Cytopathological pattern of cervical pap smears-a study among population of North Malabar in Kerala

Cited by 11 publications

References 0 publications

Profile of PAP smears done in a tertiary centre in North Kerala

Profile of PAP smears done in a tertiary centre in North Kerala

A study on cervical cancer screening in asymptomatic women using Papanicolaou smear in a tertiary care hospital in an urban area of Mumbai, India

A study on cervical pap screening with clinical correlation in a tertiary care hospital

Contact Info

Product

Resources

About